TCL Archive DRCCA Concept Approvals; RFP For Evolution Of Three Programs; RFA For Cancer Care Of Elderly, New Physician Investigator Awards October 29, 1982
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Also Von Eschenbach role in industry program raises new concerns of conflict of interest. November 23, 2005
TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
